Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5760)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2020 (publication date) through May 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mangia A, Cenderello G, Verucchi G, Ciancio A, Fontana A, Piazzolla V, Minerva N, Squillante MM, Copetti M. Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis? World J Clin Cases 2020; 8(22): 5831-5834 [PMID: 33344581 DOI: 10.12998/wjcc.v8.i22.5831] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i22/5831.htm |
| Number | Citing Articles |
| 1 |
M. I. Gonik, E. L. Bueverova, A. O. Bueverov. Hyperferritinemia, chronic hepatitis C and COVID-19: what do they have in common?. Meditsinskiy sovet = Medical Council 2023; (8): 150 doi: 10.21518/ms2023-142
|
| 2 |
Noa Krawczyk, Bianca D. Rivera, Cale Basaraba, Thomas Corbeil, Bennett Allen, Katharina Schultebraucks, Brandy F. Henry, Harold A. Pincus, Frances R. Levin, Diana Martinez. COVID‐19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems. Addiction 2023; 118(5): 857 doi: 10.1111/add.16105
|
| 3 |
Shimaa Afify, Basem Eysa, Fatma Abdel Hamid, Omnia M Abo-Elazm, Mohamed A Edris, Rabab Maher, Ahmed Abdelhalim, Muhammad Mostafa Abdel Ghaffar, Dalia A Omran, Hend Ibrahim Shousha. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World Journal of Gastroenterology 2021; 27(42): 7362-7375 doi: 10.3748/wjg.v27.i42.7362
|
| 4 |
Fares E M Ali, Zuhair M Mohammedsaleh, Mahmoud M Ali, Osama M Ghogar. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World Journal of Gastroenterology 2021; 27(15): 1531-1552 doi: 10.3748/wjg.v27.i15.1531
|
| 5 |
Viola Guardigni, Elena Rosselli Del Turco, Lorenzo Badia, Silvia Galli, Kristian Scolz, Pierluigi Viale, Gabriella Verucchi. Pre-Existing HBV and HCV Infections Do Not Affect COVID-19-Related Outcomes: An Observational Retrospective Study. Hepatitis Monthly 2021; 21(5) doi: 10.5812/hepatmon.116986
|
| 6 |
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li. Management of COVID-19 patients with chronic liver diseases and liver transplants. Annals of Hepatology 2022; 27(1): 100653 doi: 10.1016/j.aohep.2021.100653
|
| 7 |
Nitin A. John, Jyoti E. John. Implication of COVID-19 in patients of HIV with hepatitis C. Journal of Family Medicine and Primary Care 2022; 11(3): 828 doi: 10.4103/jfmpc.jfmpc_1090_21
|
| 8 |
Kai Zhu, Olivia Tsai, Daljeet Chahal, Trana Hussaini, Eric M. Yoshida. COVID-19 and Liver Disease: An Evolving Landscape. Seminars in Liver Disease 2023; 43(03): 351 doi: 10.1055/a-2157-3318
|
| 9 |
David L. Fisher , Stephen Malnick. Liver and COVID-19 - A Review and Clinical Approach. Coronaviruses 2022; 3(1) doi: 10.2174/2666796702666211005142343
|
| 10 |
Paul Middleton, Catherine Hsu, Mark P Lythgoe. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies. BMJ Open Gastroenterology 2021; 8(1): e000739 doi: 10.1136/bmjgast-2021-000739
|
| 11 |
Taghreed S Saeed Al-Rawi, Raid M Al-Ani. Liver dysfunction-related COVID-19: A narrative review. World Journal of Meta-Analysis 2023; 11(1): 5-17 doi: 10.13105/wjma.v11.i1.5
|
| 12 |
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.753249
|
| 13 |
Essamedin M. Negm, Rehab H. El-Sokkary, Mai M. Malek, Heba M. Ezzat, Ahmed E. Tawfik, Heba Ali Abed, Seham Mahmoud ELdeeb, Mohamed Sorour Mohamed, Hamdy M. Kassem, Ahmed Mosallem, Sherif M. S. Mowafy. Prevalence and outcome of chronic hepatitis C patients admitted with COVID-19 to intensive care units: a blessing in disguise. Ain-Shams Journal of Anesthesiology 2023; 15(1) doi: 10.1186/s42077-023-00396-6
|
| 14 |
Nevio Cimolai. The Complexity of Co-Infections in the Era of COVID-19. SN Comprehensive Clinical Medicine 2021; 3(7): 1502 doi: 10.1007/s42399-021-00913-4
|
| 15 |
Essamedin M. Negm. Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”. The Egyptian Journal of Bronchology 2022; 16(1) doi: 10.1186/s43168-022-00120-2
|
| 16 |
Manuela G. Neuman, Helmut K. Seitz, Rolf Teschke, Stephen Malnick, Kamisha L. Johnson-Davis, Lawrence B. Cohen, Anit German, Nicolas Hohmann, Bernhardo Moreira, George Moussa, Mihai Opris. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. Current Issues in Molecular Biology 2022; 44(3): 1294 doi: 10.3390/cimb44030087
|
| 17 |
George D Liatsos. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groups. World Journal of Gastroenterology 2023; 29(16): 2397-2432 doi: 10.3748/wjg.v29.i16.2397
|
| 18 |
Spencer R. Goble, Jose D. Debes. Hepatitis C Virus Infection and COVID-19 Inpatient Mortality. Infectious Diseases in Clinical Practice 2024; 32(5): 1394 doi: 10.1097/IPC.0000000000001394
|